| Literature DB >> 31334056 |
Archana J Lokhande1, Venkataram Mysore2.
Abstract
Striae distansae (SD) or stretch marks are very common, asymptomatic, skin condition frequently seen among females between 5 to 50 years of ages. It often causes cosmetic morbidity and psychological distress, particularly in women and in certain professions where physical appearances have significant importance. Of late, with the increasing emphasis on cosmetic management and awareness, patients approach dermatologists for stretch marks treatment. However, despite several advances, no fully effective treatment has emerged. Unfortunately, there is paucity of the strong evidence in the literature for the effective treatment of striae. A literature search using the terms 'striae distansae (SD or stretch marks' was carried out in the PubMed, Google Scholar and Medline databases. Only articles related to the treatment were considered and analysed for their data. Commonly cited treatments include topical treatments like tretinoin, glycolic acid, ascorbic acid and various lasers including (like) carbon dioxide, Er:YAG, diode, Q-switched Nd:YAG, pulse dye and excimer laser. Other devices like radiofrequency, phototherapy and therapies like platelet rich plasma, chemical peeling, microdermabrasion, needling, carboxytherapy and galvanopuncture have also been used with variable success. This article reviews all currently accepted modalities and their effectiveness in the treatment of stretch marks.Entities:
Keywords: Lasers; striae; treatment
Year: 2019 PMID: 31334056 PMCID: PMC6615396 DOI: 10.4103/idoj.IDOJ_336_18
Source DB: PubMed Journal: Indian Dermatol Online J ISSN: 2229-5178
Treatment targets of different therapies used in striae distensae
| Induction of dermal collagen production and fibroblastic activity (to improve tissue strength) |
| Reduction of lesional vascularity (especially in SR) |
| Reduction in wrinkling and roughness of skin (to improve texture) |
| Increase in pigmentation (in SA) |
| Increase in elasticity and blood perfusion |
| Improvement in cell proliferation |
| Increased skin hydration and |
| Anti-inflammatory properties |
Topicals agents used for striae distensae
| Topical agent used | Mechanism of action |
|---|---|
| Tretinoin or retinoic acid | Increase tissue collagen I levels through fibroblastic stimulation |
| Hyaluronic acid | Increase tensile resistance to mechanical forces |
| Trofolastin (Centella asiatica) | Stimulation of fibroblasts and antagonist to glucocorticoid effect |
| Silicone | Skin hydration |
| Acid peels - glycolic acid, trichloroaceticacid (TCA) | Proliferation of fibroblast and stimulate collagen production by fibroblasts |
| Ascorbic acid | Improved collagen production |
| Alphasria | Increasing volume to oppose mechanical atrophy |
| Cocoa butter | Mositurisation |
| Oils - olive oil, almond oil, coconut oil, bio oil | Action by massage and cutaneous hydration |
| Pirfenidone | Immunomodulatory, anti-inflammatory, promote collagenase, fibroblastic activity |
Procedural therapies used for striae distensae
| Type of procedure |
|---|
| Lasers |
| Ablative fractional CO2 10,600 nm |
| Non-ablative fractional Er:YAG 1540 nm |
| Non-ablative 1450 nm diode laser |
| 1064 nm Nd:YAG laser |
| Flash-pumped 585 nm pulsed dye laser |
| Cu bromide laser |
| 308 nm excimer laser |
| Light-based therapies |
| Intense pulsed light |
| UVB/UVA1 combined therapy and targeted phototherapy |
| Infrared light |
| Radiofrequency (or ablative/non-ablative) |
| Non-fractional |
| Fractional |
| Microneedle radiofrequency (MNRF) |
| Galvanopuncture |
| Carboxytherapy |
| Microdermabrasion |
| Platelet rich plasma (PRP) |
| Microneedling therapy or percutaneous collagen induction therapy |
| Chemical peeling |
Different therapies used for striae distensae
| Type of modality used in study | Type of study | Machine specifications | Frequency and total no of sittings | Results and remarks | Level of evidence |
|---|---|---|---|---|---|
| Fractional ablative CO2 laser[ | Retrospective cohort study | 10,600 nm at 10 mJ/MTZ | Single session Retrospectively reviewed | Almost 60% of patients showed ≥50% clinical improvement in SA Most of the patients were very satisfied A/E - PIH, pruritus, crusting, oozing, erythema | 4 |
| Fractional non-ablative Er glass laser[ | RCT | 1550-nm Er:YAG | 1-2 sessions with 4 week intervals | Decrease erythema index, melanin index of the treated SD lesions Skin elasticity was partially normalised with increase in epidermal thickness, collagen and elastic fibre A/E- mild, transient pain and hyperpigmentation | 2 |
| 1550 nm non-ablative fractional Er glass laser[ | Case series | Moderately high-energy sessions of 1550 nm | 5 sessions at 4 weeks interval | Dimensions of both SA and SR were decreased at 1 month and 1 year after treatment in comparison to before | 4 |
| Fractional non-ablative Er glass laser[ | Prospective cohort study | 1550 nm at 80-100 mJ/MTZ | 4-8 sessions at 4-week intervals | Mean clinical improvement of~80% after an average of 6-7 sessions Mean patient satisfaction score of 8.2/10 A/E - PIH | 4 |
| Fractional non-ablative Er glass laser[ | Cross-sectional study | 1540 nm at 70 mJ/MTZ | 3-6 sessions at 1-month interval | 50% of patients showed clinical improvement after 3 sessions and remaining 50% showed after 4-6 sessions A/E - erythema, oedema | 4 |
| Fractional non-ablative Er glass laser[ | RCT | 1550 nm at 12-18 J/cm2 | 6 sessions with 2-3 week intervals Untreated site acted as controls | 63% patients had almost 50% improvement Improvement in striae dimensions≤50% improvement was observed in texture and colour of the striae A/E - erythema, oedema, blistering | 1 |
| Fractional non-ablative Er glass laser[ | RCT | Abdomen divided into 2 parts treated with 1540 nm at 50 J/cm2 vs 1410 nm at 30 J/cm2 | 6 treatments at 3-6-week interval | All patients demonstrated clinical improvement with histopathology showing increased epidermal thickness, dermal thickness and collagen and elastin density 28% of 1410-nm treated and 33% of 1540-nm treated groups had good or excellent improvements; 71.4% and 28.6% of patients were very satisfied and moderately satisfied, respectively No significant differences between lasers A/E - 1540-nm laser - pain and 1410-nm laser - PIH, pruritus | 2 |
| PDL[ | RCT | 585 nm Four treatment protocols (fluence): 1=10 mm, 2.5 J/cm2; 2=10 mm; 3 J/cm2, 3=7 mm, 2 J/cm2; 4=7 mm, 4 J/cm2 untreated striae in same patient acted as controls | Single session | Improved aesthetic appearance and skin shadowing with all protocols Best results observed with higher fluence, i.e., 10-mm spot size+3 J/cm2 A/E - purpura, erythema, hyper-hypopigmentation | 2 |
| PDL[ | RCT | 585 nm at 3 J/cm2 | Two treatments 6 weeks apart Untreated striae as controls | No significant differences in striae area Colour improvement in SR but not in SA A/E - PIH | 2 |
| 308 nm excimer laser[ | RCT | 308 nm at 150-900 J/cm2 | Up to 15 sessions | Almost 100% patients achieved darkening and improved appearance of striae | 2 |
| XeClexcimer laser[ | RCT | 308 nm | Up to 10 sessions with weekly intervals | 80% of patients showed very poor results, without any satisfaction | 2 |
| Long-pulsed Nd:YAG laser[ | Comparative RCT | Striae divided into 3 sections and treated with 1064 nm at 75 J/cm2 vs 100 J/cm2 vs control 5 mm spot size and 15 ms pulse duration | 4 treatments at 3-week interval | Histopathological and clinical improvement in length and width of striae was seen SA showed better response to 100 J/cm2 and SR responded better with 75 J/cm2 | 2 |
| Long-pulsed Nd:YAG laser[ | Comparative RCT | 1064 nm Nd:YAG laser | 4 treatments at 4-week interval | Some clinical and histopathological improvement in SD, but it was not statistically significant | 2 |
| 1450 nm diode[ | RCT | 1450 nm at 4, 8 and 12 J/cm2 | Three sessions with 6-week intervals | Patients failed to show any improvement A/E - erythema, PIH | I |
| Tripollar RF[ | Case control | 40-50 W | Six sessions with weekly intervals | Improvement of 25-50% and 51-75% in 38.2% and 11.8% of patients, respectively Patients were slightly satisfied, satisfied and very satisfied (12%, 23% and 65% of patients, respectively No significant differences in striae surface smoothness A/E - occasional pinching, sensation during treatment | 4 |
| Nano-fractional RF[ | Case control | - | 3 sessions 4 week interval | The total surface area and the width and the length of striae alba significantly decreased from the baseline Average mean number of collagen and elastin bundles was significantly increased A/E - PIH | 3 |
| Ablative fractional microplasma RF[ | Case control | - | Four sessions every 2 weeks | Mean severity score improved by 20% Mean score from patient assessment was 2.4 (≥50%) (good to very good) A/E -erythema, oedema | 4 |
| PCT[ | Case control | Disk microneedle therapy system (DTS) | 3 sessions with 4-week intervals | Marked to excellent improvement in 43.8% with minimal-to-moderate improvement in remaining patients | 4 |
| Microdermabrasion[ | RCT | 5 sessions at weekly intervals Other half of body acted as control | Good to excellent (i.e ≥50%) improvement in 50% and mild-to-moderate improvement in the rest Greater improvement in SR Increased type 1 procollagen at mRNA levels in treated striae A/E - PIH, erythema | 2 | |
| IPL[ | Case control | 535, 550 and 580 nm at 25-35 J/cm2 | Five sessions with 3-4 week interval | Increased collagen, amide1 and beta sheet expression after IPL treatment A/E=stinging sensation | 4 |
| IPL[ | RCT | 650 nm at 13-15.5 J/cm2 vs 590 nm at 13-14.5 J/cm2 | Five sessions with 2-week intervals Different wavelengths used on opposite sides of body | Significant reductions in length and width with both treatments Significant reduction in erythema with 590-nm wavelength along with superior patient Satisfaction scores A/E=erythema, pain, burning, PIH (all more common with 590-nm wavelength) | 2 |
| UVB/UVA1 light therapy[ | RCT | UVB: 296-315 nm 1 UVA: 360-370 nm at 45-400 mJ/cm2 | Biweekly treatments for a maximum of 10 treatments | After final treatment, 5 patients had 100% pigmented striae (hyperpigmented), 3 had 76-100%, and 1 had 51-75% improvement After 12 weeks, 2 patients had 51-75% improvement, 3 had 26-50% improvement and 4 had 0-25% improvement Increase in elastic fibre to collagen ratio in 1 patient A/E -erythema, PIH | 2 |
| TCA-based easy peel solution 1 post peel cream[ | Case control | TCA: 50% | Up to 8 treatments monthly | Almost all had a 60-75% improvement with reduced depth of striae | 4 |
Level of evidence study design
| 1 Randomised, controlled trial, systematic review with meta-analysis |
| 2 Non-randomised, controlled trial, prospective, comparative cohort trial |
| 3 Case-control study, retrospective cohort study |
| 4 Case series cross-sectional study |
| 5 Expert opinion case reports (Quality rating scheme modified from the Oxford centre for evidence-based medicine for ratings of individual studies) |
Figure 1(a) Flowchart for management of striae distensae pre-treatment workup. (b) Flowchart for management of striae distensae – practical approach
Comparative analysis of different therapies used for striae distensae
| Type of modality used in study | Type of study | Machine specifications | Frequency &total no of sittings | Results and remarks | Level of evidence |
|---|---|---|---|---|---|
| Fractional non-ablative Er glass laser vs fractional ablative CO2 laser[ | Comparative RCT | Er: glass laser: 1550 nm at 50 mJ CO2 laser: 10,600 nm at 40-50 mJ | 3 sessions at 4-week intervals | Clinical improvements was observed in 90.9% of striae in both treatment groups | 2 |
| Increased skin elasticity and reduced width of striae with both treatments from baseline | |||||
| Increased epidermal thickness and collagen and elastic fibres with both lasers | |||||
| No statistically significant difference in response between either laser | |||||
| A/E - pain during treatment, PIH and crusting were more with the CO2 laser | |||||
| 585 nm PDL and the short pulsed CO2 laser[ | RCT | PDL: 585 nm at 3 J/cm2 CO2 laser: 350 mJ and 400 mJ | Single session Striae split into 3 areas and treated with both lasers and 1 control area | No improvement with either treatment | 2 |
| Succinylatedatelocollagen or placebo vs succinylatedatelocollagen or placebo + ablative fractional CO2 vs ablative fractional CO2 laser[ | Comparative RCT | CO2 laser: 50 mJ Abdomen divided into 3 areas; placebo or collagen applied twice a day | 3 laser sessions performed every 4 weeks | Increased epidermal thickness and erythema and melanin index in all laser irradiated sites but no significant differences between laser alone vs combination | 2 |
| A/E - erythema, PIH, pruritus | |||||
| Fractional ablative CO2 vs GCA + tretinoin[ | Comparative RCT | Group 1 - Fr CO2-10,600 nm at 16 J/cm2 vs Group 2-10% GCA + 0.05% tretinoin daily | 5 sessions with 2-4-week intervals; GCA + tretinoin | Significantly higher clinical improvements in striae surface area in laser group compared to topicals | 2 |
| Patient satisfaction was significantly higher in laser group | |||||
| A/E - PIH | |||||
| Fractional CO2 laser vs combination of PDL + fractional CO2 laser[ | Comparative RCT | Group 1- fractional CO2 laser | Group 13 sessions at 4 week; Group 2 - fractional CO2 laser (3 sessions) and PDL (2 sessions) alternately, with 2-week intervals (the first session was fractional CO2 laser) | Mean surface area decreased significantly in both groups | 2 |
| Combination of PDL and fractional CO2 laser was more effective | |||||
| PDL vs IPL[ | Comparative RCT | PDL: 595-nm at 2.5 J/cm2; IPL: 565 nm at 17.5 J/cm2 | Five sessions with 4-week intervals | Decreased striae width and improved skin texture with both modalities | 2 |
| SR showed better response vs SA | |||||
| PDL induced higher levels of collagen expression | |||||
| A/E - PIH erythema, pain, itching with both treatments | |||||
| XeCl excimer laser vs UVB light[ | Comparative RCT | XeCl: 308 nm UVB: 290-320 nm | Up to 10 treatments | All patients showed increase in melanin and melanocytes with both treatments | 2 |
| Multipolar RF+pulsed magnetic field[ | Comparative | - | 6 sessions | ~80% patients noticed visible improvements in SD | 4 |
| Significant mean reduction in length and width of 1.031 cm and 0.160 cm, respectively | |||||
| Bipolar RF+IR light vs fractional bipolar RF vs fractional bipolar RF + bipolar RF+IR light[ | Comparative RCT | Bipolar RF+IR light: 100 J/cm2 Fractional bipolar RF: 50-65 mJ/pin Abdomen divided into quadrants with one acting as a control | Monthly sessions for 3 months | Decrease of 21.64% in striae depth with the combined approach of all 3 treatments vs 1.73% increase in control areas | 1 |
| No significant differences in striae width | |||||
| Greater clinical improvement with combined approach of all 3 treatments vs control areas | |||||
| More reticulated pattern of collagen fibres in combination treated and fractional bipolar RF-treated areas | |||||
| Thicker reticular dermis collagen fibres in all treatment areas | |||||
| A/E - bipolar RF: transient crusts, PIH. Mild pruritus with all treatments | |||||
| Ablative fractional RF+tretinoin cream+acoustic pressure wave US vs ablative fractional RF[ | Comparative RCT | RF: 45 W Tretinoin: 0.05% US: 50 Hertz 1 80% intensity | 4 sessions every 4 weeks Topical tretinoin daily | All patients in combined treatment group showed clinical improvement | 2 |
| Four patients in RF-alone group did not show any improvements | |||||
| All patients in combined treatment group rated improvement between 76-100% vs 25% in RF-alone group | |||||
| Creation of micro channels in epidermis with reaching dermoepidermal junction with combined approach | |||||
| A/E - erythema, oedema and burning sensation in both groups PIH with RF only | |||||
| Plasma fractional RF+PRP+US[ | Case control | RF: 40-45 W | Three sessions with 3-week intervals | Excellent improvement in 33%; 38.9%, very good; 22.4%, good and 5.6%, mild | 4 |
| Average reduction in width of striae from 0.75 mm to 0.27 mm. Patients were very satisfied with treatment | |||||
| Significant increases in dermal collagen and elastic fibres A/E=PIH | |||||
| Carboxy therapy vs PRP[ | Case control | PRP injection in their right side (group A) and carboxy therapy session in their left side (group B) | Every 3-4 weeks for 4 sessions | Significant improvement in striae alba in both groups after than before treatment. | 4 |
| No significant difference between both groups as regards either percentage of improvement, response (grading scale) or patient satisfaction | |||||
| Increased fibronectin expression with carboxy therapy than PRP | |||||
| PRP vs tretinoin[ | RCT | Half of the selected striae were treated with PRP intralesional injection. The other half was treated by topical tretinoin | - | Statistically significant improvement in the SD treated with PRP and topical tretinoin cream | 2 |
| The improvement was more in the SD treated with PRP injections. Collagen and elastic fibres in the dermis were increased in all biopsies after treatment | |||||
| PCT vs fractional ablative CO2[ | RCT | PCT: Laser: 10,600 nm at 100 W | Both the treatments were given as 3 sessions with 4-week intervals | Clinical and histopathological improvements in 90% of PCT-treated group vs 50% in laser treated group | 2 |
| PCT vs MDA with sonophoresis[ | RCT | PCT andmicrodermabrasion | PCT: 3 sessions with 4-week intervals Microdermabrasion: 10 sessions over 5 months | Clinical as well as histopathological improvements in 90% of PCT-treated group vs 50% in microdermabrasion with sonophoresis treated group | 2 |
| Superficial dermabrasion vs topical tretinoin[ | Comparative RCT | Tretinoin (0.05%) daily | Topical application on daily bases vs dermabrasion weekly Both for 16 weeks | Clinical improvements with significant reductions in length and width of striae in both groups but no significant differences between treatments | 2 |
| Reduction in elastolysis, collagen fragmentation and epidermal atrophy in dermabrasion group | |||||
| A/E - pruritus, erythema, burning sensation, scaling/crusting, pain, swelling, papules | |||||
| All present in both groups | |||||
| Fractional ablative CO2 laser vs IPL[ | RCT | CO2 laser: 10,600 nm at 40 mJ IPL: 590 nm at 20-30 J/cm2 | FrCO2-5 sessions with 1-month intervals IPL - 10 sessions twice weekly for 5 months | In the laser and IPL groups, 80% and 32% were deemed to have 50% improvement, respectively | 2 |
| Significant improvements in striae width in both groups but no significant changes in striae length | |||||
| In the laser group, 80% of patients were satisfied vs 20% in the IPL group | |||||
| A/E - erythema, burning, pruritus, PIH | |||||
| PDL vs IPL[ | Case control | PDL-585 nm | 5 sessions with a 4-week interval between | Decreased striae width, improved skin texture, increased collagen expression after PDL and IPL | 4 |
| PDL induced the expression of collagen I in a highly significant compared with IPL | |||||
| Results were more in SR compared to SA | |||||
| 20% glycolic acid/0.05% tretinoin vs 20% glycolic acid/10% L-ascorbic acid[ | Comparative RCT | GCA: 20% tretinoin: 0.05% Daily for 12 weeks to opposite sides of abdomen or thigh | Clinical and histological improvements with both regimens but no differences between individual treatments | 2 | |
| Tretinoin regimen increased reticular and papillary dermal elastin content | |||||
| A/E- mild irritation, dermatitis |